-
“Big pharma is playing a bigger role in early life-science investing.” “Look for new ways to support startups. Diversity is good for us.” “Aren’t we lucky to be in this space right now?” Some thoughts from today’s panel at
#BioTrinity2018@JNJInnovation@JLABS#JJDC pic.twitter.com/Yn4rZuBauU
-


@JLABS for having an ALL FEMALE investor panel!!! (Geoffrey Ling is the moderator)#GirlPower#femaleVC#JJDC#GEVentures#SofinnovaVentures#ceosummit2018pic.twitter.com/wM8k8iytrz
-
Together with my Janssen colleagues I had the chance to visit the Israeli biotech incubator FutuRx and learn about their model.
@JLABS seems a perfect match for the FutuRx companies to further accelerate. Thanks for having me!@jnjinnovation#JJDC pic.twitter.com/qh9aehFXG1
-
World class science from MD Anderson is the foundation of Magnolia, an Accelerator newco focused on neurodegeneration
#JJDC proud investor@JNJInnovationhttps://twitter.com/NewsFromBW/status/1028945618427727873 …
-
Impressive line up of
#Medtech investors “Through the Looking Glass” - reverse pitching for entrepreneurs seeking equity investing. Our very own@Reneeryan378 @JNJInnovation presenting#JJDC strategic global investment approach at @AusBiotech#AusMedtech2019pic.twitter.com/3lL70FQY3k
-
Adapt your pitch to your audience - whether you're presenting to an Angel, corporate venture or strategic partner, know their interests and highlight how your company aligns
@JNJInnovation#JJDC Vijay Murthy at#JLABSSDpic.twitter.com/k7MKZKab73
-
Getting Funded in 2018 Investment Panel “The advantage of a corporate venture partner like
@JNJInnovation#JJDC is the access to vast knowledge, advice and mentoring capabilities within the company” -@JeanneBolger#IFLC2017pic.twitter.com/yhbkFUcwEw
-
#JJDC adds Adicet Bio to its portfolio@JNJInnovationhttps://twitter.com/BioCentury/status/1179561707418636288 … -
And we”re off! Wonderful to have
#JJDC@reneeryan378 @AusBiotech#AusMedtech2019 on the “Harnessing the Pipeline” Here with Tim O’Meara from @GEHealthcare - @JNJInnovation Making the Connectionpic.twitter.com/CuAT5XWp3A
-
87% of series A in 2017 went to two areas Oncology and rare diseases. Marianne DeBacker
#JJDC@JNJInnovation Opportunity is in balancing those amounts out over other areas.pic.twitter.com/sXEfswTZ5i
-
Delighted to be working with the great team at
@curaseninc to go after challenging neurodegenerative diseases to try to bring much needed therapies to patients.#JJDC https://twitter.com/JNJInnovation/status/1052568399891578880 …
-
Delighted to be a
#JJDC investor in Vor Biopharma, co-founded by@DrSidMukherjee. Read about his hope and vision for cancer treatments in the interview:https://twitter.com/JNJNews/status/1136633911927353345 …
-
VCs invest in TEAMS and good science so this one was impossible for
#JJDC to pass up! Can't beat Kazumi Shiosaki CEO & Shomir Ghosh CSO
https://twitter.com/MPMCapital/status/1037783785482461184 … -
2019 year in review!
#JJDC deployed >$500M in capital, made 40 new/follow-on investments. Hear from our new head of#JJDC Chris Picariello and learn about some of our investments including@RibonTx https://bit.ly/35N85hq pic.twitter.com/eu1Scla2v9
-
Looking forward to joining the "SoCalBio Networking Forum" next Monday to discuss Innovation and venture investing at Johnson & Johnson
#JJDC https://www.eventbrite.com/e/socalbio-networking-forum-tickets-41468455266?utm-medium=discovery&utm-campaign=social&utm-content=attendeeshare&aff=estw&utm-source=tw&utm-term=listing …@Eventbritepic.twitter.com/83v2aecplS
-
“The world is going
#digital and I think you’ll see us make more investments in this area.” -#ReneeRyan, Johnson & Johnson Innovation#JJDC, in the new@MedTechStrat@JNJCares@Carbon#medicaldevice@DCassakpic.twitter.com/gNDS3Zp8Lt
-
Excited to see
@JNJInnovation#JJDC@janssenglobal continuing to support neuroscience innovation to try to help patients with brain diseases.@MNakada and Thong Le are terrific!https://twitter.com/JNJInnovation/status/1029443803063545856 …
-
Excited to announce that
@claireleurent PhD MBA is joining Johnson & Johnson Innovation –#JJDC as Principal, Venture Investments, based in the Boston@JNJInnovation Center! Claire was previously at Samsung Ventures -
Big day
@NYSE for our#JNJ innovation team!#ringthebell@JNJInnovation@JLABS#JJDC#startup#JNJ@JNJNews#JLABSNYC#ringtrue#closingbellpic.twitter.com/ehd8drRYYN -
Celebrating
#badasswomen on#internationalwomansday2018#investor for@JNJNews#JJDC@MNakada, new#CEO (former Head of Immunology for@JanssenGlobal) Sue Dillon#global#Head of strategy for#JNJ external innovation Cat Oyler and me, Global Head@JNJInnovation@JLABS#BOOMpic.twitter.com/4rdB99pU6o
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.